Barbara B. Mittleman is the Director of the NIH Public-Private Partnership Program of the U.S. National Institutes of Health (NIH). In this capacity she works to develop a wide range of partnerships between the NIH and industry, foundations, academic institutions, and other entities both in the United States and abroad. Dr. Mittleman is an internist and rheumatologist and trained at the University of Pittsburgh for medical school, residency and fellowship. She came to the NIH in 1991 to pursue post-doctoral laboratory research training in cellular immunology and autoimmunity. Her current research interests include biomarkers, particularly for systemic lupus erythematosus (SLE), health disparities, and bioethics.
Philip G. Altbach is J. Donald Monan, S.J. University Professor and Director of the Center for International Higher Education in the Lynch School of Education at Boston College. He has taught at Harvard University, the University of Wisconsin-Madison, and the States University of New York at Buffalo, and been a visiting scholar at the SciencesPo, Paris, France, the University of Bombay, India, and is a guest professor at Peking University, China. He is author of Turmoil and Transition: The International Imperative in Higher Education, Comparative Higher Education, Student Politics in America, and other books. His most recent book is World Class Worldwide: Transforming Research Universities in Asia and Latin America. Philip Altbach holds a BA, MA, and PhD from the University of Chicago.
Lisa A. Bero is a Professor in the Department of Clinical Pharmacy, School of Pharmacy and Institute for Health Policy Studies, School of Medicine, University of California, San Francisco. She is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy. She is Vice Chair in the Department of Clinical Pharmacy and Chair of the UCSF Chancellor’s Advisory Committee on Conflicts of Interest. Dr. Bero is an advisor to the World Health Organization Department of Essential Medicines and Pharmaceutical Policies and serves on several national and international committees related to conflicts of interest and research, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice.
Stephanie J. Bird is an independent consultant and co-Editor-in-Chief of Science and Engineering Ethics, an international publication that explores